genOway Société anonyme (ALGEN.PA)

EUR 3.92

(0.0%)

Total Liabilities Summary of genOway Société anonyme

  • genOway Société anonyme's latest annual total liabilities in 2023 was 14.45 Million EUR , down -17.64% from previous year.
  • genOway Société anonyme's latest quarterly total liabilities in 2023 FY was 14.45 Million EUR , down -17.64% from previous quarter.
  • genOway Société anonyme reported annual total liabilities of 17.55 Million EUR in 2022, down -2.94% from previous year.
  • genOway Société anonyme reported annual total liabilities of 18.08 Million EUR in 2021, down -3.37% from previous year.
  • genOway Société anonyme reported quarterly total liabilities of 16.44 Million EUR for 2023 Q2, down 0.0% from previous quarter.
  • genOway Société anonyme reported quarterly total liabilities of 14.45 Million EUR for 2023 FY, down -17.64% from previous quarter.

Annual Total Liabilities Chart of genOway Société anonyme (2023 - 2009)

Historical Annual Total Liabilities of genOway Société anonyme (2023 - 2009)

Year Total Liabilities Total Liabilities Growth
2023 14.45 Million EUR -17.64%
2022 17.55 Million EUR -2.94%
2021 18.08 Million EUR -3.37%
2020 18.72 Million EUR 52.08%
2019 12.31 Million EUR 4.35%
2018 11.79 Million EUR 18.25%
2017 9.97 Million EUR 54.9%
2016 6.44 Million EUR 5.62%
2015 6.09 Million EUR 16.59%
2014 5.23 Million EUR 12.63%
2013 4.64 Million EUR -18.53%
2012 5.7 Million EUR -1.31%
2011 5.77 Million EUR -15.47%
2010 6.83 Million EUR -6.98%
2009 7.34 Million EUR 0.0%

Peer Total Liabilities Comparison of genOway Société anonyme

Name Total Liabilities Total Liabilities Difference
ABIONYX Pharma SA 6.91 Million EUR -109.194%
ABIVAX Société Anonyme 131.05 Million EUR 88.967%
Adocia SA 31.87 Million EUR 54.63%
Aelis Farma SA 13.08 Million EUR -10.547%
Biophytis S.A. 15.84 Million EUR 8.767%
Advicenne S.A. 24.37 Million EUR 40.684%
IntegraGen SA 5.97 Million EUR -141.806%
Medesis Pharma S.A. 6.42 Million EUR -125.009%
Neovacs S.A. 3.71 Million EUR -289.521%
NFL Biosciences SA 3.62 Million EUR -299.359%
Plant Advanced Technologies SA 6.78 Million EUR -113.193%
Quantum Genomics Société Anonyme 3.31 Million EUR -336.829%
Sensorion SA 13.22 Million EUR -9.316%
Theranexus Société Anonyme 5.01 Million EUR -188.257%
TME Pharma N.V. 2.78 Million EUR -419.193%
Valbiotis SA 13.7 Million EUR -5.482%
TheraVet SA 1.48 Million EUR -873.709%
Valerio Therapeutics Société anonyme 20.46 Million EUR 29.356%
argenx SE 402.79 Million EUR 96.41%
BioSenic S.A. 32.26 Million EUR 55.184%
Celyad Oncology SA 9.97 Million EUR -44.914%
DBV Technologies S.A. 38.74 Million USD 62.681%
Galapagos NV 1.56 Billion EUR 99.074%
Genfit S.A. 105.92 Million EUR 86.349%
GeNeuro SA 20.13 Million EUR 28.205%
Hyloris Pharmaceuticals SA 8.61 Million EUR -67.9%
Innate Pharma S.A. 132.29 Million EUR 89.07%
Inventiva S.A. 101.59 Million EUR 85.767%
MaaT Pharma SA 22.46 Million EUR 35.635%
MedinCell S.A. 77.77 Million EUR 81.407%
Nanobiotix S.A. 95.74 Million EUR 84.897%
Onward Medical N.V. 25.69 Million EUR 43.733%
Oryzon Genomics S.A. 25.12 Million EUR 42.451%
OSE Immunotherapeutics SA 59.07 Million EUR 75.525%
Oxurion NV 19.73 Million EUR 26.735%
Pharming Group N.V. 228.28 Million EUR 93.666%
Poxel S.A. 53.9 Million EUR 73.174%
GenSight Biologics S.A. 34.72 Million EUR 58.362%
Transgene SA 26.51 Million EUR 45.471%
Financière de Tubize SA 123.65 Million EUR 88.306%
UCB SA 6.56 Billion EUR 99.78%
Valneva SE 341.14 Million EUR 95.761%
Vivoryon Therapeutics N.V. 4.54 Million EUR -218.001%